KPJ Healthcare Berhad (KLSE:KPJ)
Malaysia · Delayed Price · Currency is MYR 2.750
-0.010 (-0.36%)
At close: Feb 6, 2026
KPJ Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 4,174 | 3,922 | 3,419 | 2,868 | 2,590 | 2,397 | |
Revenue Growth (YoY) | 10.84% | 14.73% | 19.18% | 10.76% | 8.03% | -12.44% |
Cost of Revenue | 2,315 | 2,167 | 1,987 | 1,696 | 1,664 | 1,495 |
Gross Profit | 1,860 | 1,755 | 1,432 | 1,172 | 925.91 | 902.56 |
Selling, General & Admin | 1,191 | 1,113 | 959.46 | 795.13 | 694.07 | 628.76 |
Other Operating Expenses | -31.49 | -27.48 | -67.34 | -28.6 | -24.01 | -28.97 |
Operating Expenses | 1,160 | 1,085 | 892.12 | 766.53 | 670.07 | 599.79 |
Operating Income | 700.1 | 670.19 | 539.79 | 405.54 | 255.85 | 302.76 |
Interest Expense | -191.71 | -197.02 | -204.89 | -194.34 | -166.74 | -163.48 |
Interest & Investment Income | 18.11 | 22.11 | 20.15 | 12.14 | 8.55 | 14.16 |
Earnings From Equity Investments | 49.05 | 49.36 | 46.76 | 47.76 | 25.86 | 16.95 |
EBT Excluding Unusual Items | 575.55 | 544.64 | 401.81 | 271.11 | 123.52 | 170.4 |
Impairment of Goodwill | - | - | - | - | -4.03 | -1.61 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.56 | 0.34 |
Asset Writedown | -8.09 | -8.09 | -20.8 | 6.71 | 3.34 | -16.51 |
Pretax Income | 567.46 | 536.54 | 381.01 | 277.82 | 123.39 | 152.62 |
Income Tax Expense | 182.83 | 171.78 | 78.41 | 75.89 | 51.01 | 41.81 |
Earnings From Continuing Operations | 384.63 | 364.77 | 302.6 | 201.93 | 72.38 | 110.81 |
Earnings From Discontinued Operations | 22.74 | 22.74 | -17.88 | -11.63 | - | - |
Net Income to Company | 407.36 | 387.5 | 284.71 | 190.31 | 72.38 | 110.81 |
Minority Interest in Earnings | -35.6 | -33.69 | -21.31 | -23.32 | -17.59 | -0.37 |
Net Income | 371.77 | 353.82 | 263.41 | 166.98 | 54.79 | 110.44 |
Net Income to Common | 371.77 | 353.82 | 263.41 | 166.98 | 54.79 | 110.44 |
Net Income Growth | 28.83% | 34.32% | 57.75% | 204.79% | -50.40% | -47.75% |
Shares Outstanding (Basic) | 4,367 | 4,364 | 4,361 | 4,341 | 4,292 | 4,279 |
Shares Outstanding (Diluted) | 4,367 | 4,364 | 4,361 | 4,444 | 4,416 | 4,460 |
Shares Change (YoY) | 0.13% | 0.07% | -1.86% | 0.64% | -0.99% | 0.00% |
EPS (Basic) | 0.09 | 0.08 | 0.06 | 0.04 | 0.01 | 0.03 |
EPS (Diluted) | 0.09 | 0.08 | 0.06 | 0.04 | 0.01 | 0.02 |
EPS Growth | 28.66% | 34.22% | 60.71% | 203.09% | -50.00% | -47.68% |
Free Cash Flow | 499.74 | 465.33 | 420.04 | 225.59 | 195.65 | 96.26 |
Free Cash Flow Per Share | 0.11 | 0.11 | 0.10 | 0.05 | 0.04 | 0.02 |
Dividend Per Share | 0.041 | 0.042 | 0.031 | 0.020 | 0.005 | 0.012 |
Dividend Growth | - | 33.87% | 55.00% | 263.64% | -54.17% | -40.00% |
Gross Margin | 44.55% | 44.75% | 41.88% | 40.86% | 35.75% | 37.65% |
Operating Margin | 16.77% | 17.09% | 15.79% | 14.14% | 9.88% | 12.63% |
Profit Margin | 8.91% | 9.02% | 7.70% | 5.82% | 2.11% | 4.61% |
Free Cash Flow Margin | 11.97% | 11.86% | 12.29% | 7.86% | 7.55% | 4.01% |
EBITDA | 922.58 | 878.56 | 737.85 | 595.48 | 441.63 | 475.46 |
EBITDA Margin | 22.10% | 22.40% | 21.58% | 20.76% | 17.05% | 19.83% |
D&A For EBITDA | 222.49 | 208.38 | 198.06 | 189.93 | 185.78 | 172.7 |
EBIT | 700.1 | 670.19 | 539.79 | 405.54 | 255.85 | 302.76 |
EBIT Margin | 16.77% | 17.09% | 15.79% | 14.14% | 9.88% | 12.63% |
Effective Tax Rate | 32.22% | 32.02% | 20.58% | 27.32% | 41.34% | 27.39% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.